Novo Nordisk has launched direct-to-consumer sales of its obesity drug Wegovy for uninsured or under-insured people at $499 per month. Skip to main content Friday 20 June 2025 . BlueSky ...

The drug has already been launched in Australia, Canada, the EU, mainland China, and Japan and, although it was rejected by the US FDA last year, is predicted to make $4.7 billion in sales from G7 ...

How exactly do weight-loss drugs work – and which ones are best? They have been called miraculous and the fastest way to lose weight. From Wegovy to Mounjaro, here’s how GLP-1 drugs work ...